ValiRx (VAL) Competitors GBX 0.72 -0.01 (-1.38%) (As of 12/20/2024 11:48 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines VAL vs. EQT, CRC, WEB, NBL, FTO, TXO, NBR, COP, HAL, and WTIShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), 2059984 (FTO.L) (FTO), 282082 (TXO.L) (TXO), 60884 (NBR.L) (NBR), Casino, Guichard-Perrachon Societe Anonyme (COP), HaloSource (HAL), and LS WTI Oil ETC (WTI). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. EQTEC Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) 282082 (TXO.L) 60884 (NBR.L) Casino, Guichard-Perrachon Societe Anonyme HaloSource LS WTI Oil ETC EQTEC (LON:EQT) and ValiRx (LON:VAL) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, community ranking, profitability, risk, analyst recommendations, dividends and media sentiment. Does the media prefer EQT or VAL? In the previous week, EQTEC's average media sentiment score of 0.00 equaled ValiRx'saverage media sentiment score. Company Overall Sentiment EQTEC Neutral ValiRx Neutral Which has more risk and volatility, EQT or VAL? EQTEC has a beta of 2.07, meaning that its share price is 107% more volatile than the S&P 500. Comparatively, ValiRx has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Do insiders & institutionals have more ownership in EQT or VAL? 1.5% of EQTEC shares are held by institutional investors. 15.6% of EQTEC shares are held by company insiders. Comparatively, 18.3% of ValiRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community prefer EQT or VAL? ValiRx received 79 more outperform votes than EQTEC when rated by MarketBeat users. However, 66.98% of users gave EQTEC an outperform vote while only 51.55% of users gave ValiRx an outperform vote. CompanyUnderperformOutperformEQTECOutperform Votes7166.98% Underperform Votes3533.02% ValiRxOutperform Votes15051.55% Underperform Votes14148.45% Which has better valuation & earnings, EQT or VAL? ValiRx has lower revenue, but higher earnings than EQTEC. ValiRx is trading at a lower price-to-earnings ratio than EQTEC, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEQTEC£3.85M0.33-£24.55M-£0.17-2.86ValiRxN/AN/A-£1.97M-£0.02-35.75 Is EQT or VAL more profitable? ValiRx's return on equity of -55.38% beat EQTEC's return on equity.Company Net Margins Return on Equity Return on Assets EQTECN/A -83.34% -14.55% ValiRx N/A -55.38%-35.98% SummaryEQTEC beats ValiRx on 6 of the 11 factors compared between the two stocks. Ad Stansberry Research2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisisDan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£946,000.00£165.68M£5.14B£1.90BDividend Yield0.63%3.64%5.09%5.45%P/E Ratio-35.75115.5190.131,861.10Price / SalesN/A18,531.021,116.25392,379.48Price / Cash62.5012.8743.1028.59Price / Book0.248.594.782.80Net Income-£1.97M-£20.67M£120.31M£155.77M7 Day Performance-7.74%-1.05%-1.92%-2.02%1 Month Performance-57.31%174.77%13.65%21.62%1 Year Performance-88.37%134.18%28.34%29.68% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.72-1.4%N/A-88.3%£946,000.00N/A-35.755,450Gap DownHigh Trading VolumeEQTEQTECN/AGBX 0.58+1.8%N/A+1,523.3%£1.48M£3.85M-3.38740CRCCircle PropertyN/AGBX 3.50-12.5%N/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AGBX 0.08-33.3%N/A-95.0%£315,000.00£49.70M14.1350Gap DownHigh Trading VolumeNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000TXO282082 (TXO.L)N/AN/AN/AN/A£0.00N/A0.00170NBR60884 (NBR.L)N/AN/AN/AN/A£0.00N/A0.0012,000High Trading VolumeCOPCasino, Guichard-Perrachon Societe AnonymeN/AN/AN/AN/A£0.00N/A0.009,500High Trading VolumeHALHaloSourceN/AN/AN/AN/A£0.00N/A0.0045,000Gap DownWTILS WTI Oil ETCN/AGBX 15.39-0.5%N/AN/A£0.00N/A0.00320News Coverage Related Companies and Tools Related Companies EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives 282082 (TXO.L) Alternatives 60884 (NBR.L) Alternatives Casino, Guichard-Perrachon Societe Anonyme Alternatives HaloSource Alternatives LS WTI Oil ETC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:VAL) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.